Prof. Hendrik Scholl, from the Institute of Molecular and Clinical Ophthalmology Basel (IOB), Switzerland, presented highly anticipated results from the “TEASE” study at the 2022 Annual Meeting of the Association for Research in Vision and Ophthalmology (ARVO) in Denver, Colorado.